Cyclin D1 gene (CCND1) mutations in endometrial cancer

Oncogene

Volumn 22, Issue 38, 2003, Pages 6115-6118

  Moreno Bueno, Gema ^a   Rodríguez Perales, Sandra ^a   Sánchez Estévez, Carolina ^a   Hardisson, David ^b,c   Sarrió, David ^a   Prat, Jaime ^d   Cigudosa, Juan C ^a   Matias Guiu, Xavier ^d   Palacios, José ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

Author keywords

Cyclin D1 expression; Cyclin D1 mutation; Endometrial carcinoma

Indexed keywords

CYCLIN D1; PROLINE; SERINE; THREONINE;

AMINO ACID SUBSTITUTION; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER CYTODIAGNOSIS; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FLUORESCENCE IN SITU HYBRIDIZATION; FRAMESHIFT MUTATION; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION;

BREAST NEOPLASMS; CARCINOMA; CYCLIN D1; DNA MUTATIONAL ANALYSIS; ENDOMETRIAL NEOPLASMS; FEMALE; GENE AMPLIFICATION; HUMANS; MUTATION; SENSITIVITY AND SPECIFICITY;

MURINAE;

EID: 0141730293     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206868     Document Type: Article

References (23)

1. Alt JR, Cleveland JL, Hannink M and Diehl JA. (2000). Genes Dev., 24, 3102-3114.
2. Campo E, Raffeld M and Jaffe ES. (1999). Semin. Hemathol., 36, 115-127.
3. Cao QJ, Einstein MH, Anderson PS, Runowicz CD, Balan R and Jones JG. (2002). Int. J. Gynecol. Pathol., 21, 147-154.
4. Diehl JA, Cheng M, Roussel MF and Sherr CJ. (1998). Genes Dev., 12, 3499-3511.
5. Diehl JA, Zindy F and Sherr CJ. (1997). Genes Dev., 11, 957-972.
6. Germain D, Russell A, Thompsonm A and Hendley J. (2000). J. Biol. Chem., 275, 12074-12079.
7. Hoechtlen-Vollmar W, Menzelm G, Bartl R, Lamerz R, Wick M and Seidel D. (2000). Br. J. Haematol., 109, 30-38.
8. Kaltz-Wittmer C, Klenk U, Glaessgen A, Aust DE, Diebold J, Lohrs U and Baretton GB. (2000). Lab. Invest., 80, 1455-1464.
9. Machin P, Catasus L, Pons C, Munozn J, Matias-Guiu X and Prat J. (2002). Hum. Pathol., 33, 206-212.
10. Moreno-Bueno G, Hardisson D, Sánchez C, Sarrió D, Cassia R, García-Rostán G and Palacios J. (2002). Oncogene, 21, 7981-7991.
11. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW. (1997). Science, 275, 1787-1790.
12. Nikaido T, Li SF, Shiozawa T and Fujii S. (1996). Cancer, 78, 1248-1253.
13. Quddus M, Latkovich P, Castellani WJ, James Sung C Steinhoff MM, Briggs RC and Miranda RN. (2002). Arch. Pathol. Lab. Med., 126, 459-463.
14. Russell A, Thompson MA, Hendley J, Trute L, Armes J and Germain D. (1999). Oncogene, 18, 1983-1991.
15. Schmitz MJ, Hendricks DT, Farley J, Taylor RR, Geradts J, Rose GS and Birrer MJ. (2000). Gynecol. Oncol., 77, 439-445.
16. Schraml P, Kononenm J, Bubendorf L, Moch H, Bissig H, Nocito A, Mihatsch MJ, Kallioniemi OP and Sauter G. (1999). Clin. Cancer Res., 5, 1966-1975.
17. Sherr CJ. (1996). Science, 274, 1672-1677 (review).
18. Sherr CJ and Roberts JM. (1999). Genes Dev., 13, 501-512 (review).
19. Simpson JF, Quan DE, O'Malley F, Odom-Maryon T and Clarke PE. (1997). Am. J. Pathol., 151, 161-168.
20. Soslow RA, Shen PU, Chung MH, Isacson C and Baergen RN. (2000). Int. J. Gynecol. Pathol., 19, 329-334.
21. Steeg PS and Zhou Q. (1998). Breast Cancer Res. Treat., 52, 17-28 (review).
22. Tsuda H, Yamamoto K, Inoue T, Uchiyama I and Umesaki N. (2000). Br. J. Cancer, 82, 675-682.
23. Weinstat-Saslow D, Merino MJ, Manrow RE, Lawrence JA, Bluth RF, Wittenbel KD, Simpson JF, Page DL and Steeg PS. (1995). Nat. Med., 1, 1257-1260.